A Pilot Study Investigating the Impact of Different IOL Designs on Subjective 2D and 3D Image Quality

NCT02409641 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lenses
Intraocular Sensitivity
Visual Acuity

Interventions

DRUG: Cyclopentolatehydrochloride 0,5% eye drops

Sponsor

Medical University of Vienna